The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...